Elon Musk's Brain Implant Company Neuralink Announces FDA Approval of In-Human Clinical Study

  • 📰 nbcbayarea
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Neuralink, the neurotech startup co-founded by Elon Musk, announced Thursday it has received approval from the Food and Drug Administration to conduct its first in-human clinical study.

No BCI company has managed to clinch the FDA's final seal of approval. But by receiving the go-ahead for a study with human patients, Neuralink is one step closer to market.

Neuralink's BCI will require patients to undergo invasive brain surgery. Its system centers around the Link, a small circular implant that processes and translates neural signals. The Link is connected to a series of thin, flexible threads inserted directly into the brain tissue where they detect neural signals.

Patients with Neuralink devices will learn to control it using the Neuralink app. Patients will then be able to control external mice and keyboards through a Bluetooth connection, according to theThe FDA's approval for an in-human study is a significant win for Neuralink after a series of recent hurdles at the company. In February, the U.S.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 596. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Elon Musk’s brain chip company Neuralink gets FDA approval: What to knowNeuralink said it has regulatory approval to conduct a clinical trial of its brain implants in people, a milestone for the company as it seeks to commercialize a device that will link human brains to computers.
مصدر: washingtonpost - 🏆 95. / 72 اقرأ أكثر »

Elon Musk's brain-implant company Neuralink says it has FDA approval for first human clinical studyElon Musk’s Neuralink said Thursday it has received regulatory approval to start the first in-human clinical study for its brain implant.
مصدر: MarketWatch - 🏆 3. / 97 اقرأ أكثر »